HemOnc Today New York

Healio.com brings you the highlights from HemOnc Today New York. Refer back to this page often to read the latest news, see perspectives and interviews with leading researchers and clinicians, and review archives of past meetings.
Meeting News CoveragePerspective

Greater understanding of resistance mechanisms needed in basal cell carcinoma

April 21, 2015
NEW YORK — Hedgehog inhibitors have demonstrated high activity and durability in patients with advanced basal cell carcinoma, and they also…
Meeting News Coverage

SLNB used in patients with thin melanomas prior to guidelines

April 18, 2015
NEW YORK — Sentinel lymph node biopsy was used in patients with thin melanomas who did not have high-risk features and who had a very low risk…
Meeting News Coverage

HD IL-2 extends OS in malignant melanoma

April 18, 2015
NEW YORK — Patients with metastatic melanoma treated with high-dose interleukin-2 demonstrated improved OS compared with historical reference…
Meeting News Coverage

Erlotinib, bevacizumab yield negligible outcome in metastatic melanoma

April 17, 2015
NEW YORK — The combination of erlotinib and bevacizumab was tolerable yet displayed minimal clinical activity in patients with metastatic…
Meeting News Coverage

Speaker discusses practical use of new technologies for melanoma

April 16, 2015
NEW YORK — A presenter at the HemOnc Today Melanoma and Cutaneous Malignancies meeting reviewed new technologies for detecting early…
Meeting News Coverage

T-VEC extends OS in patients with unresected stage III/IV melanoma

April 15, 2015
NEW YORK — Patients with unresected stage IIIb, stage IIIc or stage IV melanoma treated with talimogene laherparepvec demonstrated a durable OS…
Meeting News Coverage

Benefits of combining targeted therapy, immunotherapy remain unclear

April 14, 2015
NEW YORK — A rationale exists for the combination of targeted therapy and immunotherapy, but the value of this approach has not yet been…
Meeting News CoveragePerspective

Speaker: Screening, diagnosis of melanoma has become increasingly reliant on technology

April 14, 2015
NEW YORK — Technology is increasingly being used to screen for and diagnose melanoma, according to a presenter here. “The amount of…
Meeting News Coverage

Systemic therapy plays role in evolving paradigm for brain metastases

April 13, 2015
NEW YORK — Effective targeted therapies and immunotherapies for melanoma are likely to also be effective for the treatment of brain metastases…
Meeting News Coverage

Digital technology provides advantages, challenges for treatment of melanoma

April 13, 2015
NEW YORK — Dermatologists must adapt to digital technology in the diagnosis and treatment of melanoma, according to a presenter at…